Artemis Global Life Sciences Limited announced unaudited standalone earnings results for the third quarter and nine months ended December 31, 2017. For the quarter, the company reported revenue from operations of INR 1.02 million against INR 1.02 million a year ago. Total income from operations was INR 1.02 million against INR 1.02 million a year ago. Loss from operations before exceptional items and tax was INR 0.74 million against profit from operations before exceptional items and tax of INR 0.616 million a year ago. Loss from ordinary activities before tax was INR 0.74 million against profit from ordinary activities before tax of INR 0.616 million a year ago. Net loss for the period was INR 0.551 million or INR 0.01 basic and diluted per share before & after extraordinary items against net profit for the period of INR 0.459 million or INR 0.01 basic and diluted per share before & after extraordinary items a year ago. For the nine months, the company reported revenue from operations of INR 3.06 million against INR 3.06 million a year ago. Total income from operations was INR 4.983 million against INR 3.06 million a year ago. Loss from operations before exceptional items and tax was INR 0.135 million against profit from operations before exceptional items and tax of INR 1.830 million a year ago. Loss from ordinary activities before tax was INR 1.273 million against profit from ordinary activities before tax of INR 1.830 million a year ago. Net loss for the period was INR 1.237 million or INR 0.02 basic and diluted per share before & after extraordinary items against net profit for the period of INR 1.357 million or INR 0.02 basic and diluted per share before & after extraordinary items a year ago.